27. 3. 2014
At yesterday's regular meeting, the Krka Supervisory and Management Board drew up the proposal that Krka pays its shareholders a dividend of EUR 2.10 gross per share, which is an increase of 30% on last year's dividend.
27. 2. 2014
The Management Board of Krka presented to the public the unaudited performance results of the Krka Group and the Krka Company for 2013.
15. 11. 2013
Krka was awarded the First Prize for the best annual report among large companies in 2012 at the Best Annual Report competition organised by Finance daily newspaper for the fourteenth consecutive time. In addition, the professional committee awarded our company with a prize for the best annual report in the field of communication in 2012 among all companies.
14. 11. 2013
The Management Board of Krka held a press conference and presented to the public the performance results of the Krka Group and the Krka Company for the first nine months of 2013.
24. 9. 2013
To celebrate this year’s 25th anniversary of Krka’s antihypertensive medicines acting on the renin-angiotensin-aldosterone system (RAAS), Krka organised two international symposia on hypertension treatment The Challenges, Now and Then.